AstraZeneca Reactivates £200 Million Investment In Cambridge
AstraZeneca has reactivated £200 million of investment for its headquarters in Cambridge. The company also announced £100 million in new funding for its site in Macclesfield. This follows a previous decision to halt or review such investments.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Times Radio UK
“AstraZeneca has U-turned and reactivated £200 million of investment in its headquarters in Cambridge. It's also announced £100 million of new money for its site in Macclesfield.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade